HBV INFECTION
Clinical trials for HBV INFECTION explained in plain language.
Never miss a new study
Get alerted when new HBV INFECTION trials appear
Sign up with your email to follow new studies for HBV INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hepatitis b patients with normal ALT: can TMF suppress the virus?
Disease control OngoingThis study tests a drug called TMF (Amibufenamide) in 200 adults with chronic hepatitis B who have normal liver enzyme (ALT) levels. The goal is to see if TMF can lower the amount of hepatitis B virus in the blood to undetectable levels after 48 weeks. Participants are randomly a…
Matched conditions: HBV INFECTION
Phase: NA • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated May 11, 2026 20:37 UTC
-
New shot aims to clear hepatitis b virus in Long-Term patients
Disease control OngoingThis study tests an experimental injection called TVAX-008 in 48 adults with chronic hepatitis B (a long-term liver infection). The goal is to see if it can safely clear the hepatitis B surface antigen (HBsAg) from the blood, which would indicate strong virus control. Participant…
Matched conditions: HBV INFECTION
Phase: PHASE2 • Sponsor: Grand Theravac Life Sciences (Nanjing) Co., Ltd. • Aim: Disease control
Last updated May 04, 2026 16:18 UTC
-
New blood test score could spot liver cancer earlier in High-Risk patients
Diagnosis ENROLLING_BY_INVITATIONThis study aims to see if a new scoring system called GAAD, which combines a patient's age, gender, and two blood markers, can detect liver cancer more accurately than current methods like ultrasound or standard blood tests. Researchers will enroll 2,100 adults with chronic liver…
Matched conditions: HBV INFECTION
Phase: NA • Sponsor: Mahidol University • Aim: Diagnosis
Last updated May 14, 2026 12:03 UTC